EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled Trial

Hadia Farrukh iD, Patricia Schneider, Tess Hudson iD, Victoria Giglio, Ricardo Gehrke Becker iD, Samir Sabharwal iD, Kimmen Quan iD, Valerie Francescutti, Mira Goldberg, Sheila Sprague iD, Michelle Ghert iD, SAFETY Investigators

Current Oncology · 04.12.2025 · 32 (12) · 686

DOI: 10.3390/curroncol32120686 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Current Oncology, online erschienen am 04.12.2025. Verfasst von Hadia Farrukh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, McMaster University, Hamilton, ON L8S 4K1, Canada. Hauptthemen laut MEDLINE: Extremities, Sarcoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Cancer Society, American Academy of Orthopaedic Surgeons, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soft-tissue sarcomas (STSs) are rare malignancies predominantly found in the extremities. Surgery and radiation are standard treatments, but post-operative pulmonary surveillance, involving clinical visits and thoracic imaging, is crucial due to a high recurrence rate, most commonly to the lungs. Current pulmonary surveillance guidelines lack robust evidence. The Surveillance AFter Extremity Tumor SurgerY (SAFETY) randomized controlled trial is designed to determine the impact of pulmonary surveillance frequency (every three versus six months) and chest imaging modality (CXR versus CT) on patient-important outcomes. The pilot phase assessed feasibility of patient enrolment, protocol adherence, and data quality, as well as aggregate outcomes at two years of follow-up. 100 patients were enrolled from 300 screened patients across 17 international sites. Minor protocol deviations were common. Follow-up, data completeness and data quality met the progression criteria of 85%. Of the 100 patients, 15 died, 21 had metastases, seven had local recurrence and 30 experienced at least one serious adverse event. This SAFETY trial study established feasibility of enrolment and data quality, and confirmed the need to emphasize protocol adherence in sarcoma care. The results of this trial are expected to provide crucial evidence to standardize STS pulmonary surveillance practices, ultimately improving patient management and expectations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExtremitiesSarcomaAdultAgedFemaleHumansMaleMiddle AgedPilot Projects

Stichwörter der Autor:innen

lung metastasispatient-important outcomesrandomized controlled trialrecurrencesoft-tissue sarcomasurveillance

Autor:innen und Institutionen

  • Department of Surgery, McMaster University, Hamilton, ON L8S 4K1, Canada.
  • Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, Brazil.
  • Department of Orthopaedic Surgery, University of Cincinnati, Cincinnati, OH 45267, USA.
  • Department of Oncology, McMaster University, Hamilton, ON L8S 4K1, Canada.
  • Department of Orthopaedics, University of Maryland, Baltimore, MD 21201, USA.

ORCID-Profile: Hadia Farrukh, Tess Hudson, Ricardo Gehrke Becker, Samir Sabharwal, Kimmen Quan, Sheila Sprague, Michelle Ghert

Förderung

  • Canadian Cancer Society
  • American Academy of Orthopaedic Surgeons
  • CIHR
  • Musculoskeletal Tumor Society
  • Hamilton Academic Health Sciences Organization
  • Canadian Cancer Society Research Institute
  • Canadian Institutes of Health Research
  • American Academy of Orthopaedic Surgeons/Musculoskeletal Tumor Society

Zitieren

APA

Farrukh, H., Schneider, P., Hudson, T., Giglio, V., Becker, R. G., Sabharwal, S., Quan, K., Francescutti, V., Goldberg, M., Sprague, S., Ghert, M., & SAFETY Investigators (2025). The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled Trial. Current Oncology, 32(12), 686. https://doi.org/10.3390/curroncol32120686

Vancouver

Farrukh H, Schneider P, Hudson T, Giglio V, Becker RG, Sabharwal S, et al. The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled Trial. Current Oncology. 2025;32(12):686. doi:10.3390/curroncol32120686

BibTeX
@article{Farrukh2025,
  author = {Farrukh, Hadia and Schneider, Patricia and Hudson, Tess and Giglio, Victoria and Becker, Ricardo Gehrke and Sabharwal, Samir and Quan, Kimmen and Francescutti, Valerie and Goldberg, Mira and Sprague, Sheila and Ghert, Michelle and SAFETY Investigators, SAFETY Investigators},
  title = {The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled Trial},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {12},
  pages = {686},
  doi = {10.3390/curroncol32120686}
}
Kostenlos starten →